Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Buprenophine and Naloxone in Opiate Addicts

NCT00000355 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00000355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Buprenophine and Naloxone in Opiate Addicts
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 1
Overall status
Completed
Start date
November 30, 1994
Completion date
March 31, 1996
Enrollment
0
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-related disorders, substance-related disorders